Search

Your search keyword '"Susen, Sophie"' showing total 749 results

Search Constraints

Start Over You searched for: Author "Susen, Sophie" Remove constraint Author: "Susen, Sophie"
749 results on '"Susen, Sophie"'

Search Results

51. Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin

55. Gestion des anticoagulants oraux directs pour la chirurgie et les actes invasifs programmés : propositions réactualisées du Groupe d’intérêt en hémostase périopératoire (GIHP) – septembre 2015

56. Prophylaxis with recombinant von Willebrand factor ( rVWF ) in patients with type 3 von Willebrand disease ( VWD ): results of a post hoc analysis from a phase 3 trial

57. Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

59. Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

62. Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial.

65. A nanobody against the von Willebrand factor A3-domain detects ADAMTS13-induced proteolysis in congenital & acquired VWD

67. Tranexamic acid dose–response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study

69. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

70. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

71. Les lésions de l’endothélium vasculaire

72. Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider

74. Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Cohort

83. Big picture initiatives in bleeding disorders

84. Derivation and Validation of a Predictive Score for Respiratory Failure Worsening Leading to Secondary Intubation in COVID-19: The CERES Score

85. Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization

86. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) – March 2013

88. A Combination of Two Variants p. (Val510 =) and p. (Pro2145Thrfs * 5), Responsible for von Willebrand Disease Type 3 in a Caribbean Patient

90. ABO Blood Groups in Systemic Sclerosis: Distribution and Association with This Disease's Characteristics.

91. Plasma Markers of Neutrophil Extracellular Trap Are Linked to Survival but Not to Pulmonary Embolism in COVID-19-Related ARDS Patients

92. Prédiction de la concentration en globules rouges des caillots d'avc en combinant l'irm t2* et des données cliniques et biologiques simples

93. Longitudinal Assessment of Systemic Steroid Therapy on Hyperinflammatory Endothelial Biomarker Profiles and Serology Responses of COVID-19 Patients

94. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

95. Inflammatory Markers and Auto-Abs to Type I IFNs in COVID-19 Convalescent Plasma

97. Optogenetic and chemogenetic insights into the neurocircuitry of depression‐like behaviour: A systematic review

98. Von Willebrand disease type 2B with a novel mutation in the VWF gene

100. Is low dose Tranexamic acid less effective than a standard dose at reducing blood loss and inhibiting hyperfibrinolysis in hemorrhagic caesarean section? Multicenter double–blind placebo-controlled dose-ranging (TRACES) trial.

Catalog

Books, media, physical & digital resources